Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Lansoprazole
Teva Pharma GmbH
Healthy
3 trials -
Larotinib
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Volunteers
1 trial -
Leflunomide 20 mg Tablets
Teva Pharma GmbH
Healthy
1 trial -
Lendormin tablet
Boehringer Ingelheim
Healthy
1 trial -
Levetiracetam
Teva Pharma GmbH
Healthy
4 trials -
Light Power Density and Light Duration 40 mW/cm²*1000s
The First People's Hospital of Lianyungang
Healthy Adult Subjects
1 trial -
Liposomal Bupivacaine 13.3
Pacira Ireland Limited
Healthy
1 trial -
Lisdexamfetamine Dimesylate
Takeda
Healthy Volunteers
2 trials -
Lisdexamfetamine Dimesylate
Takeda
Healthy
1 trial -
Lofexidine
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
Lofexidine (granules for reconstitution)
BRIGHT MINDS BIOSCIENCES INC.
Normal Healthy Volunteers
1 trial -
Lofexidine HCl
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
Lofexidine hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product
1 trial -
Lofexidine hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Normal Healthy Volunteers
1 trial -
Losartan
Teva Pharma GmbH
Healthy
2 trials -
Losartan potassium/Hydrochlorothiazide
Teva Pharma GmbH
Healthy
2 trials -
Losmapimod 15 mg oral tablet
Fulcrum Therapeutics
Healthy Adult Subjects
1 trial -
Lucid-21-302
Quantum Biopharma
Healthy Participants
1 trial -
MB02-SP
Mabxience Research SL
Healthy Volunteers
1 trial -
MB04-A-01-23
Mabxience Research SL
Not applicable, Healthy Volunteers
1 trial -
MBX 2109 (Part A)
MBX Biosciences
Healthy
1 trial -
MEDITOP/2025/01
Pari Pharma GmbH
Comparative bioequivalence study in healthy volunteers under fasting conditions.
1 trial -
MGL-3196
Madrigal Pharmaceuticals EU Limited
Healthy
3 trials -
MGL-3196 Tablet
Madrigal Pharmaceuticals EU Limited
Healthy
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.